1. Mirnezami M, Rahimi H. Serum zinc level in vitiligo: A case-control study. Indian J Dermatol. 2018;63(3):227.
2. Sinani A, Roshi E, Lico R, Fida M, Dajci V. A study on the prevalence and dermatology life quality index on vitiligo in Tirana, Albania. Balkan Milit Med Rev. 2015;18(4). [
DOI:10.5455/bmmr.189331]
3. Zhang Y, Cai Y, Shi M, et al. The prevalence of vitiligo: a meta-analysis. PloS one. 2016;11(9):e0163806. [
DOI:10.1371/journal.pone.0163806] [
PMID] [
PMCID]
4. Zokaei S, Farhud DD, Keykhaei M, Yeganeh MZ, Rahimi H, Moravvej H. Cultured epidermal melanocyte transplantation in vitiligo: a review article. Iran J Pub Health. 2019;48(3):388. [
DOI:10.18502/ijph.v48i3.881]
5. Anbar T, Westerhof W, Abdel‐Rahman A, El‐Khayyat M. Evaluation of the effects of NB‐UVB in both segmental and non‐segmental vitiligo affecting different body sites. Photodermatol, Photoimmunol Photomed. 2006;22(3):157-63. [
DOI:10.1111/j.1600-0781.2006.00222.x] [
PMID]
6. Tayyebi Meibodi N, Javidi Z, Mahmodi M, et al. Evaluation of subtypes of peripheral blood lymphocytes in patients with vitiligo.J Mashhad Univ Med Sci. 2009;52(4):198-202.
7. Zhang XJ, Liu JB, Gui JP, et al. Characteristics of genetic epidemiology and genetic models for vitiligo. J Am Acad Dermatol. 2004;51(3):383-90. [
DOI:10.1016/j.jaad.2003.12.044] [
PMID]
8. Malhotra N, Dytoc M. The pathogenesis of vitiligo. J Cutan Med Surg. 2013;17(3):153-72. [
DOI:10.2310/7750.2012.12005] [
PMID]
9. Guerra L, Dellambra E, Brescia S, Raskovic D. Vitiligo: pathogenetic hypotheses and targets for current therapies. Curr Drug Metab. 2010;11(5):451-67. [
DOI:10.2174/138920010791526105] [
PMID]
10. Aydogan K, Turan O, Onart S, Karadogan S, Tunali S. Audiological abnormalities in patients with vitiligo. Exper Dermatol. 2006;31(1):110-3. [
DOI:10.1111/j.1365-2230.2005.02004.x] [
PMID]
11. Araki S, Mizuta K, Takeshita T, Morita H, Mineta H, Hoshino T. Degeneration of the stria vascularis during development in melanocyte-deficient mutant rats (Ws/Ws rats). Europ Arch Oto-rhino-laryngol. 2002;259(6):309-15. [
DOI:10.1007/s00405-002-0480-z] [
PMID]
12. Mohamed ES, Said EA, Sayed DS, Awad SM, Ahmed MH. Auditory system dysfunction in patients with vitiligo: is it a part of a systemic autoimmune process? Egypt J Otolaryngol. 2017;33(3):594-602. [
DOI:10.4103/ejo.ejo_6_17]
13. Shalaby ME-S, El-Zarea GA, Nassar A. Auditory function in vitiligo patients. Egypt Dermatol Online J. 2006;2(1):1.
14. Ezzedine K, Sheth V, Rodrigues M, et al. Vitiligo is not a cosmetic disease. J Am Acad Dermatol. 2015;73(5):883-5. [
DOI:10.1016/j.jaad.2015.07.039] [
PMID]
15. Bainbridge KE, Wallhagen MI. Hearing loss in an aging American population: extent, impact, and management. Ann Rev Pub Health. 2014;35:139-52. [
DOI:10.1146/annurev-publhealth-032013-182510] [
PMID]
16. Shukla A, Harper M, Pedersen E, et al. Hearing loss, loneliness, and social isolation: a systematic review. Otolaryngol Head Neck Surg. 2020;162(5):622-33. [
DOI:10.1177/0194599820910377] [
PMID] [
PMCID]
17. Kawakami T, Hashimoto T. Disease severity indexes and treatment evaluation criteria in vitiligo. Dermatol Res Pract. 2011;2011. [
DOI:10.1155/2011/750342] [
PMID] [
PMCID]
18. Moghaddam AY, Sayyah M, Fini EA, Talaee R. Investigation the relationship between skin involvement severity and hearing loss severity in vitiligo patients. Materia Socio-Medica. 2018;30(1):29. [
DOI:10.5455/msm.2018.30.29-31] [
PMID] [
PMCID]
19. Rahimi H, Mozafari N, Bastaninejad S, Tehranchinia Z, Samani NA. Hearing status in patients with vitiligo. Clin Cosmet Investig Dermatol. 2019;12:445. [
DOI:10.2147/CCID.S201012] [
PMID] [
PMCID]
20. Al-Mutairi N, Al-Sebeih K. Late onset vitiligo and audiological abnormalities: Is there any association? Indian J Dermatol Venereol Leprol. 2011;77(5):571. [
DOI:10.4103/0378-6323.84059] [
PMID]
21. Escalante-Ugalde C, Poblano A, de Oca EM, Lagunes R, Saúl A. No evidence of hearing loss in patients with vitiligo. Arch Dermatol. 1991;127(8):1240-. [
DOI:10.1001/archderm.1991.01680070142026] [
PMID]
22. Lien KH, Ger TY, Chi CC. Association of vitiligo with high‐frequency sensorineural hearing loss: a systematic review and meta‐analysis. J Europ Acad Dermatol Venereol. 2022;36(3):373-9. [
DOI:10.1111/jdv.17815] [
PMID]
23. Ma SH, Ang MD, Chang YT, Dai YX. Association between vitiligo and hearing loss. J Am Acad Dermatol. 2021;85(6):1465-72. [
DOI:10.1016/j.jaad.2020.12.029] [
PMID]
24. Murillo-Cuesta S, Contreras J, Zurita E, et al. Melanin precursors prevent premature age-related and noise -induced hearing loss in albino mice. Pigment Cell Melanoma Res 2010; 23(1): 72-83. . [
DOI:10.1111/j.1755-148X.2009.00646.x] [
PMID]
25. Shajil E, Chatterjee S, Agrawal D, Bagchi T, Begum R. Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes..Indian J Exp Biol.2006;44(7):526-39.
26. Liu X, Yan D. Ageing and hearing loss. J Pathol. 2007;211(2):188-97. [
DOI:10.1002/path.2102] [
PMID]
27. Perossini M, Turio E, Perossini T, Cei G, Barachini P. Vitiligo: ocular and electrophysiological findings. Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale, Societa Italiana di Dermatologia e Sifilografia. 2010;145(2):141-9.
28. Elsaied MA, Naga YAA, Abdo A. Evaluation of brain stem auditory evoked response in vitiligo patients. J Pan-Arab League Dermatologists. 2008;19(1):91-7.